Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.

Eilber FC, Brennan MF, Eilber FR, Eckardt JJ, Grobmyer SR, Riedel E, Forscher C, Maki RG, Singer S.

Ann Surg. 2007 Jul;246(1):105-13.

2.

The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.

Eilber FC, Eilber FR, Eckardt J, Rosen G, Riedel E, Maki RG, Brennan MF, Singer S.

Ann Surg. 2004 Oct;240(4):686-95; discussion 695-7.

3.

A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients.

Canter RJ, Qin LX, Maki RG, Brennan MF, Ladanyi M, Singer S.

Clin Cancer Res. 2008 Dec 15;14(24):8191-7. doi: 10.1158/1078-0432.CCR-08-0843.

4.

Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients.

Chen Y, Yang Y, Wang C, Shi Y.

J Surg Oncol. 2012 Aug 1;106(2):162-8. doi: 10.1002/jso.23061. Epub 2012 Feb 1.

PMID:
22297839
5.

Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.

Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, Brennan MF.

J Clin Oncol. 2000 May;18(10):2087-94.

PMID:
10811674
6.

[Evaluation of prognostic factors for synovial sarcoma].

Du ZY, Guo W, Yang RL, Yan TQ, Li DS.

Zhonghua Wai Ke Za Zhi. 2011 Nov;49(11):991-4. Chinese.

PMID:
22333419
7.

Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution.

Pisters PW, Patel SR, Varma DG, Cheng SC, Chen NP, Nguyen HT, Feig BW, Pollack A, Pollock RE, Benjamin RS.

J Clin Oncol. 1997 Dec;15(12):3481-7.

PMID:
9396401
8.

Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.

Chou YS, Liu CY, Chen WM, Chen TH, Chen PC, Wu HT, Chiou HJ, Shiau CY, Wu YC, Liu CL, Chao TC, Tzeng CH, Yen CC.

J Surg Oncol. 2012 Aug 1;106(2):155-61. doi: 10.1002/jso.23060. Epub 2012 Feb 1.

PMID:
22297812
9.

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

Italiano A, Penel N, Robin YM, Bui B, Le Cesne A, Piperno-Neumann S, Tubiana-Hulin M, Bompas E, Chevreau C, Isambert N, Leyvraz S, du Chatelard PP, Thyss A, Coindre JM, Blay JY.

Ann Oncol. 2009 Mar;20(3):425-30. doi: 10.1093/annonc/mdn678. Epub 2008 Dec 16.

10.

Synovial sarcoma: the importance of size and location for survival.

Deshmukh R, Mankin HJ, Singer S.

Clin Orthop Relat Res. 2004 Feb;(419):155-61.

PMID:
15021147
11.

High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.

Yalcin B, Pamir A, Buyukcelik A, Utkan G, Akbulut H, Demirkazik A, Icli F.

Exp Oncol. 2004 Dec;26(4):320-5.

PMID:
15627067
12.

Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41-60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999.

Bacci G, Ferrari S, Mercuri M, Longhi A, Fabbri N, Galletti S, Forni C, Balladelli A, Serra M, Picci P.

Acta Orthop. 2007 Jun;78(3):377-84.

PMID:
17611853
13.

High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.

Lee SH, Chang MH, Baek KK, Han B, Lim T, Lee J, Park JO.

Oncology. 2011;80(3-4):257-61. doi: 10.1159/000328795. Epub 2011 Jul 6.

PMID:
21734417
14.

Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival.

Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM.

J Clin Oncol. 1996 Apr;14(4):1201-8.

PMID:
8648375
15.
16.

Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma.

Weiser MR, Downey RJ, Leung DH, Brennan MF.

J Am Coll Surg. 2000 Aug;191(2):184-90; discussion 190-1.

PMID:
10945362
17.

Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.

Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM.

J Clin Oncol. 2000 Nov 15;18(22):3794-803.

PMID:
11078492
18.

Preoperative regional therapy for extremity sarcoma. A tricenter update.

Wanebo HJ, Temple WJ, Popp MB, Constable W, Aron B, Cunningham SL.

Cancer. 1995 May 1;75(9):2299-306.

19.

Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.

Stanelle EJ, Christison-Lagay ER, Healey JH, Singer S, Meyers PA, La Quaglia MP.

Ann Surg Oncol. 2013 Jan;20(1):73-9. doi: 10.1245/s10434-012-2587-9. Epub 2012 Aug 10.

PMID:
22878620
20.

Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.

Mullen JT, Kobayashi W, Wang JJ, Harmon DC, Choy E, Hornicek FJ, Rosenberg AE, Chen YL, Spiro IJ, DeLaney TF.

Cancer. 2012 Aug 1;118(15):3758-65. doi: 10.1002/cncr.26696. Epub 2011 Dec 16.

Items per page

Supplemental Content

Write to the Help Desk